Novartis' programme providing free access to its spinal muscular atrophy (SMA) gene therapy Zolgensma is being scaled back to a dozen countries worldwide, according to the company. First introduced in ...
21h
Google Nexus
Get all latest & breaking news on Google Nexus. Watch videos, top stories and articles on Google Nexus at moneycontrol.com.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results